Einat Brill Almon - Net Worth and Insider Trading
Einat Brill Almon Net Worth
The estimated net worth of Einat Brill Almon is at least $0 dollars as of 2024-04-19. Einat Brill Almon is the SVP, Product Development of Protalix BioTherapeutics Inc and owns about 0 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $0. Details can be seen in Einat Brill Almon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Einat Brill Almon has not made any transactions after 2012-05-02 and currently still holds the listed stock(s).
Transaction Summary of Einat Brill Almon
Einat Brill Almon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Einat Brill Almon owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Einat Brill Almon’s form 4 insider trades.
Insider Ownership Summary of Einat Brill Almon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | VP & Product Development |
Einat Brill Almon Latest Holdings Summary
Einat Brill Almon currently owns a total of 1 stock. Einat Brill Almon owns 0 shares of Protalix BioTherapeutics Inc (PLX) as of May 2, 2012, with a value of $0.
Latest Holdings of Einat Brill Almon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | 0 | 1.12 | 0 |
Holding Weightings of Einat Brill Almon
Einat Brill Almon Form 4 Trading Tracker
According to the SEC Form 4 filings, Einat Brill Almon has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the sale of 16,685 shares on May 2, 2012, which brought Einat Brill Almon around $1 Million.
Insider Trading History of Einat Brill Almon
- 1
Einat Brill Almon Trading Performance
Einat Brill Almon Ownership Network
Ownership Network List of Einat Brill Almon
Ownership Network Relation of Einat Brill Almon
Einat Brill Almon Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Einat Brill Almon is the VP & Product Development of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Einat Brill Almon made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Einat Brill Almon Mailing Address
Above is the net worth, insider trading, and ownership report for Einat Brill Almon. You might contact Einat Brill Almon via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
